1.   

Adamowicz Ph., Legrand B., Guerche J. & Prunet P. (1974). Un nouveau procedé de concentration et de purification du virus. Application du virus de la fièvre aphteuse produit sur cellules BHK21 pour l’obtention des vaccins hautement purifiés. Bull. OIE, 81, 1125-1150.
 

2.   

Amarel-Doel C.M.F., Owen N.E., Ferris N.P., Kitching R.P. & Doel T.R. (1993). Detection of foot-and-mouth disease viral sequences in clinical specimens and ethyleneimine-inacctivated preparations by the polymerase chain reaction. Vaccine, 11, 415-421.
 

3.   

Auge De Mello P., Gomes I. & Bahnemann H.G. (1989). The vaccination of young cattle with an oil adjuvant foot-and-mouth disease vaccine. Bol. Centr. Panam. Fiebre. Aftosa, 55, 3-14.
 

4.   

Bahnemann H.G. (1975). Binary ethyleneimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch. Virol., 47, 47-56.
 

5.   

Barnett P.V., Pullen L., Williams L. & Doel T.R. (1996). International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine, 14, 1187-1198.
 

6.   

Barteling S.Z. & Vreeswijk Z. (1991). Developments in foot-and-mouth disease vaccines. Vaccine, 9, 75-88.
 

7.   

Bastos A.D.S. (1998). Detection and characterization of foot-and-mouth disease virus in sub-Saharan Africa. Onderstepoort J. Vet. Res., 65, 37-47.
 

8.   

Bergmann I.E., De Mello P.A., Neitzert E., Beck & Gomez, I. (1993). Diagnosis of persistent aphthovirus infection and its differentiation from vaccination response in cattle by use of enzyme-linked immunoelectrotransfer blot analysis with bioengineered non-structural viral antigens. Am. J. Vet. Res., 54, 825-831.
 

9.   

Clarke J.B. & Spier R.E. (1980). Variation in the susceptibility of BHK populations and cloned cell lines to three strains of foot-and-mouth disease virus. Arch. Virol., 63, 1-9.
 

10.   

De Diego M., Brocchi E., Mackay D. & De Simone F. (1997). The use of the non-structural polyprotein 3ABC of FMD virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch. Virol., 142, 2021-2033.
 

11.   

Doel T.R. & Baccarini P.J. (1981). Thermal stability of FMDV. Arch. Virol., 70, 21-32.
 

12.   

Doel T.R. & Collen T. (1982). Qualitative assessment of 146S particles of FMDV in preparations destined for vaccines. J. Biol. Stand., 10, 69-81.
 

13.   

Doel T.R., Fletton B. & Staple R.F. (1982). Further developments in the quantification of small RNA viruses by UV photometry of sucrose density gradients. Dev. Biol. Stand., 50, 209-219.
 

14.   

Doel T.R. & Pullen L. (1990). International bank for foot-and-mouth disease vaccines: stability studies with virus concentrates and vaccines prepared from them. Vaccine, 8, 473-478.
 

15.   

Doel T.R. & Staple R.F. (1982). The elution of FMDV from vaccines adjuvanted with aluminium hydroxide and with saponin. J. Biol. Stand., 10, 185-195.
 

16.   

Doel T.R., Williams L. & Barnett P.V. (1994). Emergency vaccination against foot-and-mouth disease. The rate of development of immunity and its implications for the carrier state. Vaccine, 12, 592-600.
 

17.   

European Pharmacopoeia (1986). Second Edition. Editions of the Council of Europe, Strasbourg, France.
 

18.   

European Pharmacopoeia (1993). Second Edition. Monograph No. 63. Editions of the Council of Europe, Strasbourg, France.
 

19.   

European Pharmacopoeia (1997). Third Edition. Section 5: 5.1.1. and 5.1.2. Editions of the Council of Europe, Strasbourg, France.
 

20.   

Ferris N.P. & Dawson M. (1988). Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular disease. Vet. Microbiol., 16, 201-209.
 

21.   

Food and Agricultural Organization of the United NAtions (FAO) (1984). Emerging Diseases of Livestock. Vol. 1. The Diseases and their Diagnosis, Geering W.A., ed. FAO, Rome, Italy, 43-51.
 

22.   

Golding S.M., Hedger R.S., Talbot P. & Watson J. (1976). Radial immunodiffusions and serum neutralisation techniques for the assay of antibodies to swine vesicular disease. Res. Vet. Sci., 20, 142-147.
 

23.   

Hamblin C., Barnett I.T.R. & Hedger R.S. (1986). A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. J. Immunol. Methods, 93, 115-121.
 

24.   

Hamblin C., Kitching R.P., Donaldson A.I., Crowther J.R. & Barnett I.T.R. (1987). Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. 3. Evaluation of antibodies after infection and vaccination. Epidemiol. Infect., 99, 733-744
 

25.   

Herbert W.J. (1965). Multiple emulsions. A new form of mineral-oil antigen adjuvant. Lancet, II. 771.
 

26.   

Kitching R.P. & Donaldson A.I. (1987). Collection and transportation of specimens for vesicular virus investigation. Rev. sci. Tech. Off. int. Epiz., 6, 263-272.
 

27.   

Mackay D.K.J, Forsyth M.A., Davies P.R., Berlinzani, A., Belsham G.J., Flint M. & Ryan M.D. (1997). Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine, 16, 446-459.
 

28.   

McVicar J.W. & Sutmoller P. (1970). Foot-and-mouth disease: the agar gel immunodiffusion precipitin test for antibody to virus-infection-associated (VIA) antigen as a tool for epizootiologic surveys. Am. J. Epidemiol., 92, 273-278.
 

29.   

Ministry of Agriculture, Fisheries and Food (1986). Foot-and-mouth disease. Ageing of lesions. Her Majesty’s Stationery Office, London, UK.
 

30.   

Neitzert E., Beck E., Auge de Mello P., Gomes I. & Bergmann I.E. (1991). Expression of the aphthovirus RNA polymerase gene in Escherichia coli and its use together with other bioengineered non-structural antigens in detection of late persistent infections. Virology, 184, 799-804.
 

31.   

Roeder P.L. & Le Blanc Smith P.M. (1987). The detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis. Res. Vet. Sci., 43, 225-232.
 

32.   

Samuel A.R., Ouldridge E.J., Arrowsmith A.E.M., Kitching R.P. & Knowles N.J. (1990). Serological analysis of type O isolates of FMD from the Middle East 1981-88. Vaccine, 8, 390-395.
 

33.   

Skinner H.H. (1960). Some techniques for producing and studying attenuated strains of the virus of foot and mouth disease. Bull. OIE, 53, 634-650.
 

34.   

Sorensen K.J., Madsen K.G., Madsen E.S., Salt J.S., Nquindi J. & Mackay D.K.J. (1998). Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Arch. Virol., 143, 1461-1476.
 

35.   

Strebel K., Beck E., Strohmaier D. & Schaller H. (1986). Characterisation of foot-and-mouth disease virus gene products with antisera against bacterially synthesised fusion proteins. J. Virol., 57, 983-991.
 

36.   

Van Maanen C. (1990). A complex-trapping-blocking (CTB) ELISA, using monoclonal antibodies and detecting specifically antibodies directed against foot and mouth disease types A, O and C. 1. Method and characteristics. Vet. Microbiol., 24, 171-178.
 

37.   

Vianna Filho Y.L., Astudillo V., Gomes I., Fernandez G., Rozas C.E.E., Ravison J.A. & Alonso A. (1993). Potency control of foot-and-mouth disease vaccine in cattle. Comparison of the 50% protective dose and protection against generalisation. Vaccine, 11-14, 1424-1428.
 

38.   

Wagner G.G., Card J.L. & Cowan K.M. (1970). Immunochemical studies of foot-and-mouth disease virus. VII. Characterization of foot-and-mouth disease virus concentrated by polyethylene glycol precipitation. Arch. Ges. Virusforsch., 30, 343-352.
 

39.   

Woodbury E.L., Ilott M.C., Brown C.C. & Salt J.S. (1995). Optimization of an in situ hybridization technique for the detection of foot-and-mouth disease virus in bovine tissues using the digoxigenin system. J. Virol. Methods, 51, 89-94.